SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (7381)1/9/2019 10:11:02 AM
From: Biotech Jim  Read Replies (1) | Respond to of 7424
 
I thought I posted this, but too many things going on, confusing me.

Otsuka has a DM-quinidine combo, similar ideas as AXSM with DM-Bupropion, originally for MDD. Now this combo is de-prioritized for reasons due to either DDI or tox. (rumored to be tox in humans, I know no details of SAEs).

What is to stop taking the two generics?